Johnson Controls International PLC vs Nuwellis Inc — how do they compare? Johnson Controls International PLC trades at $155.29 (market cap $93.74B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Johnson Controls International PLC is far larger — about 172697.1× Nuwellis Inc's market cap, and Johnson Controls International PLC pays a 1.03% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| JCI | NUWE | |
|---|---|---|
Market Cap | $93.74B | $542.80K |
Sector | Industrials | Technology |
52-Week High | $154.76 | $220.50 |
52-Week Low | $103.52 | $1.42 |
Enterprise Value | $102.58B | -$1.27M |
Dividend Yield | 1.03% | — |
Signals from Pluang's Aura AI — not financial advice
JCI trades at $150.70, down 0.99% on the day, with a strong bullish technical signal from moving averages. The company reported robust Q3 2026 earnings, beating estimates with $1.42 EPS and raising full-year guidance, driven by double-digit organic sales growth and record backlog. Analyst consensus is strongly positive with a $168.25 price target and no sell ratings. Recent news highlights efficiency leadership and AI-related thermal management innovations.
The outlook remains favorable given earnings momentum and strategic positioning in high-demand sectors like data centers. Key risks include execution on growth targets and macroeconomic sensitivity. The stock presents a growth opportunity supported by fundamental strength and bullish sentiment, though valuation multiples are elevated.
No Aura AI signal available yet.
Trailing returns across standard periods
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →